STOCK TITAN
  1. Home
  2. Sec-filings
  3. RPTX
  4. [EFFECT] Repare Therapeutics Inc. SEC Filing

[EFFECT] Repare Therapeutics Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 30, 2026
Accession Number: 0001193125-26-027404
Submission Type: POS AM
CIK: 0001808158
Company Name: Repare Therapeutics Inc.
File Number: 333-281298

Source: View Original Filing on SEC EDGAR

Repare Therapeutics Inc.

NASDAQ:RPTX

View RPTX Stock Overview →

RPTX Rankings

#4971 Ranked by Market Cap
N/A Ranked by Dividends

RPTX Latest News

Jan 16, 2026
Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.
Dec 24, 2025
Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration
Nov 20, 2025
Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc.
Nov 14, 2025
Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.
Oct 13, 2025
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

RPTX Latest SEC Filings

Feb 18, 2026
[15-12G] Repare Therapeutics Inc. SEC Filing
Jan 30, 2026
[Form 4] Repare Therapeutics Inc. Insider Trading Activity
Jan 30, 2026
[SCHEDULE 13D/A] Repare Therapeutics Inc. Amended Major Shareholder Report
Jan 28, 2026
[Form 4] Repare Therapeutics Inc. Insider Trading Activity
Jan 28, 2026
[Form 4] Repare Therapeutics Inc. Insider Trading Activity

RPTX Stock Data

114.24M
39.69M
Biotechnology
Pharmaceutical Preparations
Link
Canada
SAINT-LAURENT